|
Re: Travel Point of Interest
|
2
|
Resverlogix Corp.
|
Dec 22, 2017 02:52PM
|
|
Re: Why news has to come out Thursday imo....walking in the enemy's shoes
|
2
|
Resverlogix Corp.
|
Jan 30, 2019 02:52PM
|
|
Re: We Need The Futility Analysis
|
2
|
Resverlogix Corp.
|
Feb 07, 2018 01:09AM
|
|
Re: Epigenetics and Coronavirus
|
2
|
Resverlogix Corp.
|
Mar 23, 2020 05:10PM
|
|
Re: Don's discount
|
2
|
Resverlogix Corp.
|
Feb 07, 2018 01:21AM
|
|
Re: New MD&A posted
|
2
|
Resverlogix Corp.
|
Dec 18, 2019 03:55PM
|
|
Re: EVERSANA: Partnering & Licensing.
|
2
|
Resverlogix Corp.
|
Jul 15, 2021 12:42PM
|
|
Re: BETonMACE Placebo Estimate
|
2
|
Resverlogix Corp.
|
Feb 20, 2019 12:52AM
|
|
Re: Apabetalone for non diabetics or normal cholesterol?
|
2
|
Resverlogix Corp.
|
Dec 10, 2019 05:59PM
|
|
Re: Warrants
|
2
|
Resverlogix Corp.
|
Aug 09, 2018 01:21AM
|
|
Re: What if
|
2
|
Resverlogix Corp.
|
Mar 06, 2019 04:44PM
|
|
Re: Games being played on the share price
|
2
|
Resverlogix Corp.
|
May 01, 2019 12:54PM
|
|
Re: Recent findings point to BET protein and ACE2 inhibition as possible means to slow and reduce the impact of COVID-19....
|
2
|
Resverlogix Corp.
|
Mar 23, 2020 05:48PM
|
|
Re: ... removed posts????
|
2
|
Resverlogix Corp.
|
Oct 29, 2017 05:31PM
|
|
Zenith Epigentics and Resverlogix update 22 Jan 2018
|
2
|
Zenith Epigenetics
|
Jan 31, 2018 04:03PM
|
|
Re: What if
|
2
|
Resverlogix Corp.
|
Mar 06, 2019 05:07PM
|
|
Re: Updated Van Leeuwenhoeck Analyst Report by Marcel Wijma 5/2/2019
|
2
|
Resverlogix Corp.
|
May 03, 2019 02:15PM
|
|
Re: Biogen/Eisai Scrap Aducanumab
|
2
|
Resverlogix Corp.
|
Mar 24, 2019 03:35PM
|
|
Potential Deals
|
2
|
Zenith Epigenetics
|
Oct 29, 2022 02:49PM
|
|
How many of the RVX.WT's have been exercise?
|
2
|
Resverlogix Corp.
|
Dec 03, 2020 12:53PM
|
